Republic of Moldova vs Turkmenistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Republic of Moldova
0.3%
in 2024
Turkmenistan
0.3%
in 2024
Republic of Moldova rank
85th
Turkmenistan rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Republic of Moldova
- Turkmenistan
How they compare
Republic of Moldova currently reports 0.3% against 0.3% in Turkmenistan, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Turkmenistan ahead.
Republic of Moldova ranks 85th and Turkmenistan ranks 85th of 246 countries.
Across the 2 decades both report, Republic of Moldova averaged higher in 1 and Turkmenistan in 1.
Head to head by decade
| Decade | Republic of Moldova | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.0% | Turkmenistan |
| 2020s | 0.3% | 0.3% | 0.0% | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Republic of Moldova or Turkmenistan?
- Republic of Moldova, at 0.3% against 0.3% in Turkmenistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Republic of Moldova and Turkmenistan?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Turkmenistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Republic of Moldova and Turkmenistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Republic of Moldova ranks 85th and Turkmenistan ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.